Jihong Chen is the Vice President and Head of Biostatistics at Alnylam Pharmaceuticals, leading statistical strategy for drug development. He has progressed through multiple leadership roles at the company and holds a Ph. D. from the Georgia Institute of Technology, with prior experience as a global statistical lead for oncology compounds.
Information regarding Jihongs personal life is not publicly available, but he maintains an interest in his alma maters, Tsinghua University and the Georgia Institute of Technology. His focus appears dedicated to his professional endeavors and team growth.
He has co-authored pivotal clinical trial publications for Alnylams RNAi therapeutics in The New England Journal of Medicine.